GLYCIDOL MODULATION OF THE IMMUNE RESPONSES IN FEMALE B6C3F1 MICE

REFERENCES

• Irwin R. D., Eustis S. L., Stefanski S., Haseman J. Carcinogenicity of Glycidol in F344 Rats and B6C3F1 Mice. J Appl Toxicol 1996; 16: 201–209
   PubMed Web of Science ®Google Scholar
• Jackson H., Campbell I. S. C., Jones A. R. Is Glycidol an Active Intermediate in the Antifertility Action of Alpha-chlorhydrin in Male Rats. Nature 1970; 226: 88–87
   PubMedGoogle Scholar
• Slott H., Harris F. F. Teratogenicity and embryolethality of acrolein and structurally related compounds in rats. Teratology 1985; 32: 65–72
   PubMedGoogle Scholar
• Marks T. A., Gerling F. S., Staples R. E. Teratogenic Evaluation of Epichlorhydrin in the Mouse and Rat and Glycidol in the Mouse. J Toxicol Environ Health 1982; 9: 87–96
   PubMed Web of Science ®Google Scholar
• Canter D. A., Zeiger E., Haworth S., Lawlor T., Mortelmans K., Speck W. Comparative Mutagenicity of Aliphatic Epoxides in Salmonella. Mutat Res 1986; 172: 105–138
   PubMed Web of Science ®Google Scholar
• Segal A., Solomon J. J., Mukai F. In Vitro Reactions of Glycidol With Pyrimidine Bases in Calf Thymus DNA. Cancer Biochem Biophys 1990; 11: 59–67
   PubMedGoogle Scholar
• Smith R. A., Cohen S. M., Lawson T. A. Acrolein Mutagenicity in the V79 Assay. Carcinogenesis 1990; 23: 497–498
   Google Scholar
• Foureman P., Mason J. M., Valencia R., Zimmering S. Chemical Mutagenesis Testing in Drosophila. X. Results of 70 Coded Chemicals Tested for the National Toxicology Program. Environ Mol Mutagen 1994; 23: 208–227
   PubMed Web of Science ®Google Scholar
• Lijinsky W., Kovatch R. M. A Study of the Carcinogenicity of Glycidol in Syrian Hamsters. Toxicol Ind Health 1992; 8: 267–271
   PubMed Web of Science ®Google Scholar
• Kobayashi M., Kobayashi H., Pollard R. B., Suzuki F. A Pathogenic Role of Th2 Cells and Their Cytokine Products on the Pulmonary Metastasis of Murine B16 Melanoma. J Immunol 1998; 160: 5869–5873
   PubMed Web of Science ®Google Scholar
• Abbas A. K., Lichtman A. H., Pober J. S. Cellular and Molecular. Immunology W.B. Saunders Company, Philadelphia 1991
   Google Scholar
• Hassall C. D., Brendel K., Gandolfi A. J. Regulation of a S(trans-1,2-dichlorovinyl)-L-cysteine-induced Renal Tubular Toxicity by Glutathione. J Appl Toxicol 1983; 3: 321–325
   PubMedGoogle Scholar
• Jerne N. K., Nordin A. A. Plaque Formation in Agar by Single Antibody-Producing Cells. Science 1963; 140: 405–406
   Web of Science ®Google Scholar
• Holsapple M. P., Munson A. E., Munson J. A., Bick P. H. Suppression of Cell-mediated Immunocompetence After Subchronic Exposure to Diethylstilbestrol in Female B6C3F1 Mice. J Pharmacol Exp Ther 1983; 227: 130–138
   PubMed Web of Science ®Google Scholar
• Cao W., Sikorski E. E., Fuchs B. A., Stern M. L., Luster M. I., Munson A. E. The B Lymphocyte is the Immune Cell Target for 2',3'-dideoxyadenosine. Toxicol Appl Pharmacol 1990; 105: 492–502
   PubMed Web of Science ®Google Scholar
• Germolec D. R., Maronpot R. R., Ackermann M. F., Vore S. J., Dittrich K., Rosenthal G. J., Luster M. I. Lack of a Relationship Between Immune Function and Chemically Induced Hepatocarcinogenesis in B6C3F1 Mice. Cancer Immunol Immunother 1988; 105: 121–127
   Google Scholar
• Geissler K., Tricot G., Leemhuis T., Walker E., Broxmeyer H. E. Differentiation-inducing Effect of Recombinant Human Tumor Necrosis Factor Alpha and Gamma-interferon In Vitro on Blast Cells From Patients With Acute Myeloid Leukemia and Myeloid Blast Crisis of Chronic Myeloid Leukemia. Cancer Res 1989; 49: 3057–3062
   PubMed Web of Science ®Google Scholar
• Reynolds C. W., Herberman R. B. In Vitro Augmentation of Rat Natural Killer (NK) Cell Activity. J Immunol 1981; 127: 1581–1585
   Google Scholar
• Murray M. J., Kerkvliet N. I., Ward E. C., Dean J. H. Models for the Evaluation of Tumor Resistance Following Chemical or Drug Exposure. Immunotoxicology and Immunopharmacology, J. H. Dean, M. I. Luster, A. E. Munson, H. Amos. Raven Press, New York 1985; 113–122
   Google Scholar
• Morahan P. S., Klykken P. C., Smith S. H., Harris L. S., Munson A. E. Effects of Cannabinoids on Host Resistance to Listeria monocytogenes and Herpes Simplex Virus. Infect Immun 1979; 23: 670–674
   PubMed Web of Science ®Google Scholar
• White K. L., Jr., Lysy H. H., McCay J. A., Anderson A. C. Modulation of Serum Complement Levels Following Exposure to Polychlorinated Dibenzo-p-dioxins. Toxicol Appl Pharmacol 1986; 84: 209–219
   PubMed Web of Science ®Google Scholar
• North R. J., Dunn P. L., Conlan J. W. Murine Listeriosis as a Model of Antimicrobial Defense. Immunol Rev 1997; 158: 27–36
   PubMed Web of Science ®Google Scholar
• Fidler I. J., Gersten D. M., Hart I. R. The Biology of Cancer Invasion and Metastasis. Adv Cancer Res 1978; 28: 149–250
   PubMedGoogle Scholar
• Hanna N., Burton R. C. Definitive Evidence That Natural Killer (NK) Cells Inhibit Experimental Tumor Metastases In Vivo. J Immunol 1981; 127: 1754–1758
   PubMed Web of Science ®Google Scholar
• Parhar R. S., Lala P. K. Amelioration of B16F10 Melanoma Lung Metastasis in Mice by a Combination Therapy With Indomethacin and Interleukin 2. J Exp Med 1987; 165: 14–28
   PubMed Web of Science ®Google Scholar
• Selgrade M. K., Daniels M. J., Dean J. H. Correlation Between Chemical Suppression of Natural Killer Cell Activity in Mice and Susceptibility to Cytomegalovirus: Rationale for Applying Murine Cytomegalovirus as a Host Resistance Model and for Interpreting Immunotoxicity Testing in Terms of Risk of Disease. J Toxicol Environ Health 1992; 37: 123–37
   PubMed Web of Science ®Google Scholar
• Parez-Blas M., Regueiro J. R., Ruiz-Contreras J. R., Arnaiz-Villena A. T Lymphocyte Anergy During Acute Infectious Mononucleosis is Restricted to the Clonotypic Receptor Activation Pathway. Clin Exp Immunol 1992; 89: 83–88
   PubMed Web of Science ®Google Scholar
• Wilson A. S., Tingle M. D., Kelly M. D., Park B. K. Evaluation of the Generation of Genotoxic and Cytotoxic Metabolites of Benzo[a]pyrene, Aflatoxin B1, Naphthalene and Tamoxifen Using Human Liver Microsomes and Human Lymphocytes. Hum Exp Toxicol 1995; 14: 507–515
   PubMed Web of Science ®Google Scholar
• Michael A., Hackett J. J., Bennett M., Kumar V., Yuan D. Regulation of B Lymphocytes by Natural Killer Cells. Role of IFN-Gamma. J Immunol 1989; 142: 1095–1101
   PubMed Web of Science ®Google Scholar
• National Toxicology Program (NTP). Toxicology and Carcinogenesis Studies of Glycidol (Cas No. 556-52-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). NTP Technical Report No. 374, U. S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, NC 1990; 12
   Google Scholar
• Janeway C. A., Jr., Travers P. Immunobiology: The Immune System in Health and Disease. Current Biology Ld., New York 1994; 9: 24–9:25
   Google Scholar
• Nomeir A. A., Silveira D. M., Ferrala N. F., Markham P. M., McComish M. F., Ghanayem B. I., Chadwick M. Comparative Disposition of 2,3-epoxy-1-Propanol (Glycidol) in Rats Following Oral and Intravenous Administration. J Toxicol Environ Health 1995; 44: 203–217
   PubMed Web of Science ®Google Scholar